Combined archive search across FBI Vault, SPLC, PHMPT, ACIP, NIH grants, the Federal Writers' Project, and other collections we've ingested.
John Damon Chodera · SLOAN-KETTERING INST CAN RESEARCH · 2022 · $6,599,276 — SARS-CoV-2 continues to cause severe morbidity and mortality in the current pandemic and future RNA virus pandemics are inevitable. Clinical-trial-ready antivirals are lacking for all RNA viruses of pandemic potential. It is imperative that the world have access to an arsenal of compounds ready to b…
PETER MYLER · SEATTLE CHILDREN'S HOSPITAL · 2022 · $386,529 — To apply state-of-the-art, high-throughput structural biology technologies to experimentally characterize the three-dimensional atomic structure of targeted proteins on the NIAID Category A-C priority pathogens list and organisms causing emerging and re-emerging infectious diseases. This program als…
ETHAN DMITROVSKY · LEIDOS BIOMEDICAL RESEARCH, INC. · 2022 · $57,909,079 — The purpose of the National Cancer Institute’s SARS-CoV-2 Serological Sciences Network (SeroNet) is to study the immune response to COVID-19 by developing and deploying serological assays of the highest specificity and sensitivity, expanding the national testing capacity for SARS-CoV-2 antibodies, a…
TIMOTHY STEDMAN · AMERICAN TYPE CULTURE COLLECTION · 2022 · $2,924,707 — This contract provides unique and quality-assured infectious reagents and resources to the scientific community for use in basic research and product development. The scope of this contract includes the acquisition, authentication, production, preservation, storage, and distribution of research and …
Jean-Laurent Casanova · ROCKEFELLER UNIVERSITY · 2022 · $74,534 — Project Summary In December 2019, a novel coronavirus (SARS-CoV-2) emerged in the city of Wuhan, China, and quickly spread worldwide, with an increasing number of cases and deaths. In populations naive to this new pathogen, there has been immense inter-individual clinical variability among infected …
DEBORAH S HASIN · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · 2022 · $255,746 — Coronavirus Disease 2019 (COVID-19) caused by SARS-CoV-2 is a global pandemic. While most COVID-19 cases are mild or moderate, severe cases (~15%) require hospitalization, critical cases (~5%) require intensive care, and many deaths occur. Males, Blacks and Hispanics are at greater risk for COVID-19…
John Damon Chodera · SLOAN-KETTERING INST CAN RESEARCH · 2022 · $67,673,902 — PROJECT SUMMARY/ABSTRACT - Overall SARS-CoV-2 continues to cause severe morbidity and mortality in the ongoing pandemic. Future RNA virus epidemics and pandemics are inevitable. New clinical-trial-ready antivirals are urgently needed RNA viruses of pandemic potential. COVID-19 has further underscore…
Reuben S Harris · UNIVERSITY OF MINNESOTA · 2022 · $66,431,207 — Overall – Midwest AViDD Center ABSTRACT The Midwest Anti-Viral Drug Development (AViDD) Center was formalized as a direct response to NIAID U19 RFA RFA-AI-21-050 “Emergency Awards: AViDD Centers for Pathogens of Pandemic Concern”. The Co- PIs of the Midwest AViDD Center are Reuben Harris and Fang L…
Matthew Rizzo · UNIVERSITY OF NEBRASKA MEDICAL CENTER · 2022 · $60,285 — Project Summary: This application from the Great Plains IDeA Clinical and Translational Research (GP IDeA-CTR) network responds to NIGMS call (NOT-GM-22-026) for Urgent Competitive Revisions to IDeA Programs for SARS-CoV-2 Surveillance Studies. Our innovative approach addresses three specific aims (…
Mohamed Abdel Mohsen · RUSH UNIVERSITY MEDICAL CENTER · 2022 · $208,746 — PROJECT SUMMARY Recent data show that 10-30% of coronavirus disease 2019 (COVID-19) patients do not fully recover and suffer from a wide range of symptoms that persist after the SARS-CoV-2 infection has been cleared (so-called post- COVID-19 syndrome or Long Hauler). Severe COVID-19 and associated r…
Catherine A. Gao · NORTHWESTERN UNIVERSITY AT CHICAGO · 2022 · $85,550 — A. Project Summary and Abstract The goals of this NRSA postdoctoral fellowship proposal are: 1) to facilitate Dr. Catherine Gao’s development as an independent physician-scientist and an expert in the handling, integration, and computational analyses of complex datasets, and 2) to model transitions …
Christian L. Lorson · UNIVERSITY OF MISSOURI-COLUMBIA · 2022 · $2,340,729 — The objective of the parent G20 grant is to provide state of the art, highly safe and secure biocontainment facilities and services to faculty, student and staff researchers at the MU Laboratory for Infectious Diseases, one of 12 NIH/NIAID Regional Biocontainment Laboratories. The LIDR/MURBL is c…
Alexander Viloria Winnett · CALIFORNIA INSTITUTE OF TECHNOLOGY · 2022 · $51,752 — PROJECT SUMMARY Morbidity and mortality in COVID-19 is the result of an exaggerated inflammatory response causing severe tissue and organ damage. However, the biological mechanism for why some individuals progress from initially stable to ultimately critical condition has not been fully elucidated. …
JUDITH FEINBERG · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · 2022 · $156,195 — Project Summary/Abstract The COVID-19 pandemic caused by SARS-CoV-2 has resulted in social distancing measures, the total consequences of which, particularly as they relate to substance use and drug overdose deaths, are unknown. News reports and early studies have suggested increases in opioid overd…
SENT VIA EMAIL Advisory Committee on Immunization Practices Centers for Disease Control and Prevention [email protected] Re: Supplement to December 5, 2025 Presentation Titled Development of the U.S. Childhood Vaccination Schedule: With a Focus on Suggested Improvements To ACIP: Please find herein additional sources for various slides for the above -referenced presentation. As disclosed in that presentation, I am the Manag ing Partner of Siri & Glimstad LLP which has…
Tracy Beth Høeg, M.D., Ph.D. FDA Ex Officio to ACIP Senior Advisor for Clinical Sciences Office of the Commissioner (OC) &Center for Biologics Evaluation and Research (CBER)US Food and Drug Administration Core Childhood Vaccination Schedules: An International Perspective with focus on the US & Denmark 3 Danish- US double citizen MD (WI, USA- MCW), Residency UC DavisPhD -Epidemiology & Public Health (U Copenhagen) 4 45 peer reviewed publications -last 5 years focus on infectious…
Considerations and Query for the Advisory Committee for Immunization Practices Presented by Dr. Evelyn Griffin, MD, FACOG, IFMCP Child/Adolescent Immunization Schedule Work Group Vaccinations during Pregnancy Work Group HPV Work GroupVaccines and Aluminum Adjuvants Background Child/Adolescent Immunization Schedule Work Group Discussion Objectives ACIP Charter: provide “advice and guidance to the Director of the CDC regarding the use of vaccines and related agents” •Consideration of an…
Rapid Systematic Review of the Safety of MMRV Vaccine A. Background The measles -mumps -rubella -varicella (MMRV) vaccine (ProQuad, Merck) was licensed in the United States in 2005 for use in children 12 months through 12 years of age. While not licensed for use in the United States, Priorix -Tetra, a MMRV vaccine manufactured by GlaxoSmithKline , first received licensing in some European countries in 2006, and in Canada in 2007. Both ProQuad and Priorix -Tetra are tetravalent…
1 Briefing Document : Policy Recommendations for Use of Measles , Mumps , Rubella, and Varicella (MMRV) Vaccine in the United States Overall Summary: • Current ACIP/CDC recommendations for MMRV vaccine use in the U .S. summary (MMWR, May 2010): o The routinely recommended ages for measles, mumps, rubella and varicella vaccination are 12 –15 months for the first dose and 4 –6 years for the second dose. Both the first and second dose can be administered at other…
Background on Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Arjun Srinivasan, MD, MS, MBA Acting Chief Medical Officer National Center for Immunization and Respiratory Di seases ACIP Meeting September 18, 2025 National Center for Immunization & Respiratory Dise ases During the last major rubella epidemic in the U.S. (1964-1965), in 1 year: –11,000 pregnant women lost their babies –2,100 newborns died –20,000 born with congenital rubella syndrome, causing deaf ness, heart…